Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...

Among the diffuse aggressive lymphomas, diffuse large-cell histology (DLCL) is most common. In the past, older patients often received dose-reduced, potentially curative, aggressive regimens.

For certain lymphomas that are either aggressive or very slow-growing, surgery may be used to remove the cancer. The type of surgery depends on the type of lymphoma and where it has formed in the ...

Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

“Some of the symptoms of lymphoma include persistent fever, fatigue and swollen glands, which often lead patients to assume ...

including in patients with aggressive lymphoma who had received previous autologous CAR T-cell therapy, an area of continued unmet need," they added. All patients with follicular lymphoma had a ...

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced a collaboration with BeiGene Ltd., a global oncology company that intends to change its name to ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...